These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17431542)

  • 1. Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors.
    Newton HB; Dalton J; Goldlust S; Pearl D
    J Neurooncol; 2007 Sep; 84(3):293-6. PubMed ID: 17431542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients.
    Newton HB; Goldlust SA; Pearl D
    J Neurooncol; 2006 May; 78(1):99-102. PubMed ID: 16541329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam monotherapy--outcomes from an epilepsy clinic.
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
    Lim DA; Tarapore P; Chang E; Burt M; Chakalian L; Barbaro N; Chang S; Lamborn KR; McDermott MW
    J Neurooncol; 2009 Jul; 93(3):349-54. PubMed ID: 19169651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy.
    Ben-Menachem E; Edrich P; Van Vleymen B; Sander JW; Schmidt B
    Epilepsy Res; 2003 Feb; 53(1-2):57-64. PubMed ID: 12576168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of anti-epileptic drugs in patients with gliomas and seizures.
    van Breemen MS; Rijsman RM; Taphoorn MJ; Walchenbach R; Zwinkels H; Vecht CJ
    J Neurol; 2009 Sep; 256(9):1519-26. PubMed ID: 19434440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.
    Ben-Menachem E; Falter U
    Epilepsia; 2000 Oct; 41(10):1276-83. PubMed ID: 11051122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of levetiracetam in hospitalized patients.
    Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam therapy in patients with brain tumour and epilepsy.
    Maschio M; Albani F; Baruzzi A; Zarabla A; Dinapoli L; Pace A; Pompili A; Carapella CM; Occhipinti E; Jandolo B
    J Neurooncol; 2006 Oct; 80(1):97-100. PubMed ID: 16685465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial.
    Glauser TA; Pellock JM; Bebin EM; Fountain NB; Ritter FJ; Jensen CM; Shields WD
    Epilepsia; 2002 May; 43(5):518-24. PubMed ID: 12027913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open Label Trial of Add on Lacosamide Versus High Dose Levetiracetam Monotherapy in Patients With Breakthrough Seizures.
    Lee JW; Alam J; Llewellyn N; Hurwitz S; Bubrick EB; Sarkis RA; Weisholtz D; Yu H; Putta S; Dworetzky BA; Pennell PB
    Clin Neuropharmacol; 2016; 39(3):128-31. PubMed ID: 26992155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.
    Rossetti AO; Jeckelmann S; Novy J; Roth P; Weller M; Stupp R
    Neuro Oncol; 2014 Apr; 16(4):584-8. PubMed ID: 24311644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model.
    Talos DM; Chang M; Kosaras B; Fitzgerald E; Murphy A; Folkerth RD; Jensen FE
    Pediatr Res; 2013 Jan; 73(1):24-30. PubMed ID: 23138400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.
    Kerkhof M; Dielemans JC; van Breemen MS; Zwinkels H; Walchenbach R; Taphoorn MJ; Vecht CJ
    Neuro Oncol; 2013 Jul; 15(7):961-7. PubMed ID: 23680820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery.
    Zachenhofer I; Donat M; Oberndorfer S; Roessler K
    J Neurooncol; 2011 Jan; 101(1):101-6. PubMed ID: 20526797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam monotherapy for elderly patients with epilepsy.
    Alsaadi TM; Koopmans S; Apperson M; Farias S
    Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas.
    Garbossa D; Panciani PP; Angeleri R; Battaglia L; Tartara F; Ajello M; Agnoletti A; Versari P; Ducati A; Fontanella M; Spena G
    Neurol India; 2013; 61(2):131-7. PubMed ID: 23644311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life.
    Maschio M; Dinapoli L; Sperati F; Pace A; Fabi A; Vidiri A; Muti P
    J Neurooncol; 2011 Aug; 104(1):205-14. PubMed ID: 21107994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.